Personalized ‘cocktails’ of antibiotics, probiotics and prebiotics hold promise in treating IBS, pilot study finds

Personalized “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), according to research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April…